Johannes Hamann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Johannes Hamann has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
Peter Brieger
Kbo-Isar-Amper Clinic, Academic Teaching Hospital of Ludwig-Maximilians University, Munich, Germany
8 shared publicationsStephan Heres
Kbo-Isar-Amper-Klinikum, Haar, Germany
4 shared publicationsAdele Brucks
Department of Psychiatry and Psychotherapy of Technical, University of Munich, München, Germany
3 shared publicationsFabian Holzhüter
Klinik und Poliklinik für Psychiatrie und Psychotherapie Technische Universität München Munich Germany
3 shared publications- Reinhold Kilian
Section of Health Economics and Health Services Research, Department of Psychiatry and Psychotherapy II, Ulm University at Bezirkskrankenhaus Günzburg, Günzburg, Germany
3 shared publications - Tamara Waldmann
Section of Health Economics and Health Services Research, Department of Psychiatry and Psychotherapy II, Ulm University at Bezirkskrankenhaus Günzburg, Günzburg, Germany
3 shared publications
Latest Publications
- Open Access
- 1 April 2026
- Published by Springer Nature in BMC Psychiatry
- Vol. 26 (1)
Exploring the role of carers in psychiatric home treatment: qualitative multi-method study
Background: This qualitative study explored the roles, experiences, and needs of informal carers such as family and close friends in acute psychiatric home treatment in Germany. Methods: Data was collected through individual interviews, focus groups, and participant diaries with 27 carers and analyzed using grounded theory methodology. Results: The findings highlight the central yet multifaceted role carers play in facilitating care - initiating treatment, providing emotional containment, supporting daily functioning, and acting as intermediaries between service users and professionals. However, these roles were often poorly defined, leading to uncertainty, role conflicts, and occasional exclusion from the treatment process. Limited or unclear communication about expectations, responsibilities, and boundaries exacerbated this ambiguity. Carers also reported significant emotional and practical burdens, sometimes reaching a level of strain that jeopardized the continuation of home treatment. Recognition of their contributions, proactive engagement by the treatment team, and tailored support strategies were identified as key facilitators of positive involvement. Conclusions: The results underscore the need to systematically embed role clarification, structured collaboration, and carer support into the design and delivery of home treatment services. Future research should further explore how explicit clearly defined role negotiation and early joint planning meetings can enhance carer involvement while mitigating strain. Trial registration: German Clinical Trials Register (DRKS), DRKS00022476. Registered December 3 rd 2020, https://drks.de/search/de/trial/DRKS00022476 ; ClinicalTrials.gov, Identifier: NCT0474550. Registered February 9th 2021.
- 1 April 2026
- Published by Springer Nature in BMC Psychiatry
- Vol. 26 (1)
Open AccessExploring the role of carers in psychiatric home treatment: qualitative multi-method study
Background: This qualitative study explored the roles, experiences, and needs of informal carers such as family and close friends in acute psychiatric home treatment in Germany. Methods: Data was collected through individual interviews, focus groups, and participant diaries with 27 carers and analyzed using grounded theory methodology. Results: The findings highlight the central yet multifaceted role carers play in facilitating care - initiating treatment, providing emotional containment, supporting daily functioning, and acting as intermediaries between service users and professionals. However, these roles were often poorly defined, leading to uncertainty, role conflicts, and occasional exclusion from the treatment process. Limited or unclear communication about expectations, responsibilities, and boundaries exacerbated this ambiguity. Carers also reported significant emotional and practical burdens, sometimes reaching a level of strain that jeopardized the continuation of home treatment. Recognition of their contributions, proactive engagement by the treatment team, and tailored support strategies were identified as key facilitators of positive involvement. Conclusions: The results underscore the need to systematically embed role clarification, structured collaboration, and carer support into the design and delivery of home treatment services. Future research should further explore how explicit clearly defined role negotiation and early joint planning meetings can enhance carer involvement while mitigating strain. Trial registration: German Clinical Trials Register (DRKS), DRKS00022476. Registered December 3 rd 2020, https://drks.de/search/de/trial/DRKS00022476 ; ClinicalTrials.gov, Identifier: NCT0474550. Registered February 9th 2021.
- Open Access
- 24 July 2023
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 66 (1) , e55
The cost-utility of a return-to-work intervention in comparison to routine care for patients with mental disorders in Germany: Results from the RETURN project
Background: Only two-thirds of patients admitted to psychiatric wards return to their previous jobs. Return-to-work interventions in Germany are investigated for their effectiveness, but information regarding cost-effectiveness is lacking. This study investigates the cost-utility of a return-to-work intervention for patients with mental disorders compared to treatment as usual (TAU). Methods: We used data from a cluster-randomised controlled trial including 166 patients from 28 inpatient psychiatric wards providing data at 6- and 12-month follow-ups. Health and social care service use was measured with the Client Sociodemographic and Service Receipt Inventory. Quality of life was measured with the EQ-5D-3L questionnaire. Cost-utility analysis was performed by calculating additional costs per one additional QALY (Quality-Adjusted Life Years) gained by receiving the support of return-to-work experts, in comparison to TAU. Results: No significant cost or QALY difference between the intervention and control groups has been detected. The return-to-work intervention cannot be identified as cost-effective in comparison to TAU. Conclusions: The employment of return-to-work experts could not reach the threshold of providing good value for money. TAU, therefore, seems to be sufficient support for the target group.
- 24 July 2023
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 66 (1) , e55
Open AccessThe cost-utility of a return-to-work intervention in comparison to routine care for patients with mental disorders in Germany: Results from the RETURN project
Background: Only two-thirds of patients admitted to psychiatric wards return to their previous jobs. Return-to-work interventions in Germany are investigated for their effectiveness, but information regarding cost-effectiveness is lacking. This study investigates the cost-utility of a return-to-work intervention for patients with mental disorders compared to treatment as usual (TAU). Methods: We used data from a cluster-randomised controlled trial including 166 patients from 28 inpatient psychiatric wards providing data at 6- and 12-month follow-ups. Health and social care service use was measured with the Client Sociodemographic and Service Receipt Inventory. Quality of life was measured with the EQ-5D-3L questionnaire. Cost-utility analysis was performed by calculating additional costs per one additional QALY (Quality-Adjusted Life Years) gained by receiving the support of return-to-work experts, in comparison to TAU. Results: No significant cost or QALY difference between the intervention and control groups has been detected. The return-to-work intervention cannot be identified as cost-effective in comparison to TAU. Conclusions: The employment of return-to-work experts could not reach the threshold of providing good value for money. TAU, therefore, seems to be sufficient support for the target group.
- Open Access
- 9 January 2023
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 66 (1) , 1-21
Supporting return to work after psychiatric hospitalization—A cluster randomized study (RETURN-study)
Background: If people with episodic mental-health conditions lose their job due to an episode of their mental illness, they often experience personal negative consequences. Therefore, reintegration after sick leave is critical to avoid unfavorable courses of disease, longer inability to work, long payment of sickness benefits, and unemployment. Existing return-to-work (RTW) programs have mainly focused on “common mental disorders” and often used very elaborate and costly interventions without yielding convincing effects. It was the aim of the RETURN study to evaluate an easy-to-implement RTW intervention specifically addressing persons with mental illnesses being so severe that they require inpatient treatment. Methods: The RETURN study was a multi-center, cluster-randomized controlled trial in acute psychiatric wards addressing inpatients suffering from a psychiatric disorder. In intervention wards, case managers (RTW experts) were introduced who supported patients in their RTW process, while in control wards treatment, as usual, was continued. Results: A total of 268 patients were recruited for the trial. Patients in the intervention group had more often returned to their workplace at 6 and 12 months, which was also mirrored in more days at work. These group differences were statistically significant at 6 months. However, for the main outcome (days at work at 12 months), differences were no longer statistically significant (p = 0.14). Intervention patients returned to their workplace earlier than patients in the control group (p = 0.040). Conclusions: The RETURN intervention has shown the potential of case-management interventions when addressing RTW. Further analyses, especially the qualitative ones, may help to better understand limitations and potential areas for improvement.
- 9 January 2023
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 66 (1) , 1-21
Open AccessSupporting return to work after psychiatric hospitalization—A cluster randomized study (RETURN-study)
Background: If people with episodic mental-health conditions lose their job due to an episode of their mental illness, they often experience personal negative consequences. Therefore, reintegration after sick leave is critical to avoid unfavorable courses of disease, longer inability to work, long payment of sickness benefits, and unemployment. Existing return-to-work (RTW) programs have mainly focused on “common mental disorders” and often used very elaborate and costly interventions without yielding convincing effects. It was the aim of the RETURN study to evaluate an easy-to-implement RTW intervention specifically addressing persons with mental illnesses being so severe that they require inpatient treatment. Methods: The RETURN study was a multi-center, cluster-randomized controlled trial in acute psychiatric wards addressing inpatients suffering from a psychiatric disorder. In intervention wards, case managers (RTW experts) were introduced who supported patients in their RTW process, while in control wards treatment, as usual, was continued. Results: A total of 268 patients were recruited for the trial. Patients in the intervention group had more often returned to their workplace at 6 and 12 months, which was also mirrored in more days at work. These group differences were statistically significant at 6 months. However, for the main outcome (days at work at 12 months), differences were no longer statistically significant (p = 0.14). Intervention patients returned to their workplace earlier than patients in the control group (p = 0.040). Conclusions: The RETURN intervention has shown the potential of case-management interventions when addressing RTW. Further analyses, especially the qualitative ones, may help to better understand limitations and potential areas for improvement.
- Open Access
- 2 January 2023
- Published by SAGE Publications in International Journal of Social Psychiatry
- Vol. 69 (4) , 949-956
How do employees currently admitted to acute psychiatric inpatient units rate their psychosocial working conditions with the COPSOQ (Copenhagen Psychosocial Questionnaire)
Background: In recent years it could be shown that psychosocial working conditions and mental health of employees are closely correlated. One well-established instrument to measure psychosocial stress at work is the COPSOQ (Copenhagen Psychosocial Questionnaire, German Standard Version). It is an 84 item self-rating instrument addressing several domains of psychosocial working conditions and is generally used for risk assessments in companies. Aims: To examine associations between COPSOQ ratings with clinical features and symptoms of employees who currently suffer from an episode of a mental illness requiring inpatient treatment. Method: For 265 inpatients with mental disorders who participated in a cluster randomized trial (RETURN-study) COPSOQ-data were available as part of the baseline data acquisition. These data were compared with the German COPSOQ validation sample of the Freiburg research center for occupational sciences (FFAW; approximately 250,000 participants). For subdomains of the COPSOQ that showed major and significant differences between the two samples regression analyses were done to predict COPSOQ scores within the RETURN-sample. Results: Psychiatric inpatients did not assess their working conditions significantly different compared to the population based FFAW sample. However, with regard to the effects of working conditions (general health, burnout, presenteeism, and intention to leave the job) there were major differences between the two samples with the clinical sample expressing more negative views. In the RETURN sample these were predicted by a greater expression of depressive symptoms. Conclusions: The linkage between work and mental wellbeing is complex. Mental illness is not necessarily a result of poor working conditions, while good working conditions may not in every case prevent symptoms of bad health, even if such associations exist.
- 2 January 2023
- Published by SAGE Publications in International Journal of Social Psychiatry
- Vol. 69 (4) , 949-956
Open AccessHow do employees currently admitted to acute psychiatric inpatient units rate their psychosocial working conditions with the COPSOQ (Copenhagen Psychosocial Questionnaire)
Background: In recent years it could be shown that psychosocial working conditions and mental health of employees are closely correlated. One well-established instrument to measure psychosocial stress at work is the COPSOQ (Copenhagen Psychosocial Questionnaire, German Standard Version). It is an 84 item self-rating instrument addressing several domains of psychosocial working conditions and is generally used for risk assessments in companies. Aims: To examine associations between COPSOQ ratings with clinical features and symptoms of employees who currently suffer from an episode of a mental illness requiring inpatient treatment. Method: For 265 inpatients with mental disorders who participated in a cluster randomized trial (RETURN-study) COPSOQ-data were available as part of the baseline data acquisition. These data were compared with the German COPSOQ validation sample of the Freiburg research center for occupational sciences (FFAW; approximately 250,000 participants). For subdomains of the COPSOQ that showed major and significant differences between the two samples regression analyses were done to predict COPSOQ scores within the RETURN-sample. Results: Psychiatric inpatients did not assess their working conditions significantly different compared to the population based FFAW sample. However, with regard to the effects of working conditions (general health, burnout, presenteeism, and intention to leave the job) there were major differences between the two samples with the clinical sample expressing more negative views. In the RETURN sample these were predicted by a greater expression of depressive symptoms. Conclusions: The linkage between work and mental wellbeing is complex. Mental illness is not necessarily a result of poor working conditions, while good working conditions may not in every case prevent symptoms of bad health, even if such associations exist.
- 9 June 2022
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 35 (4) , 293-301
Return-to-work interventions for persons/employees with mental illnesses
Purpose of review: Mental illnesses are among the most common diseases worldwide. Cases of inability to work caused by mental illness are frequent and the related economic burden is immense. A successful reintegration into their work environment of those patients who were on sick leave due to a mental illness is an important prognostic factor for the further course of the disease and helps reducing financial consequences. It was the aim of the present review to give an overview of the status quo of return-to-work interventions in the international literature. Recent findings: Main themes of interventions addressing return to work of persons with mental illnesses are the provision of psychotherapeutic support with or without combining these approaches with work directed interventions. Personal contact of employees, mental healthcare staff and supervisors may be helpful with regard to facilitating return to work. Summary: Current return to work interventions are mostly elaborate, extensive and expensive without convincing results regarding work related outcome parameters. A variety of reasons might be responsible for this finding, including heterogeneity of outcomes, a poor definition of return-to-work-interventions and the complexity of the issue (involving multiple stakeholders).
- 9 June 2022
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 35 (4) , 293-301
Return-to-work interventions for persons/employees with mental illnesses
Purpose of review: Mental illnesses are among the most common diseases worldwide. Cases of inability to work caused by mental illness are frequent and the related economic burden is immense. A successful reintegration into their work environment of those patients who were on sick leave due to a mental illness is an important prognostic factor for the further course of the disease and helps reducing financial consequences. It was the aim of the present review to give an overview of the status quo of return-to-work interventions in the international literature. Recent findings: Main themes of interventions addressing return to work of persons with mental illnesses are the provision of psychotherapeutic support with or without combining these approaches with work directed interventions. Personal contact of employees, mental healthcare staff and supervisors may be helpful with regard to facilitating return to work. Summary: Current return to work interventions are mostly elaborate, extensive and expensive without convincing results regarding work related outcome parameters. A variety of reasons might be responsible for this finding, including heterogeneity of outcomes, a poor definition of return-to-work-interventions and the complexity of the issue (involving multiple stakeholders).
- Open Access
- 1 March 2022
- Published by Georg Thieme Verlag KG in Nervenheilkunde
- Vol. 41 (04) , 211
Suizid: Wir müssen reden
Suizid ist mehr als ein medizinisches oder psychiatrisches Problem. Das Thema Suizid umfasst medizinische, psychiatrische, psychotherapeutische, psychologische, aber auch philosophische, ethische, juristische, gesellschaftliche und politische Aspekte. Wir erleben hier ein Spannungsfeld: Suizide bringen viel Leid, und es ist eine Aufgabe der Gesellschaft und der Hilfesysteme, Suizide durch Präventionsmaßnahmen zu vermeiden oder durch therapeutische Bemühungen zu verhindern. Suizide widerspiegeln immer wieder ein Verzweifeln am Leben; und wir haben uns zu fragen, welche äußeren Umstände und inneren Zustände für diese Verzweiflung jeweils verantwortlich und wie sie zu verändern sind. Dennoch gibt es auch den Aspekt der persönlichen Freiheit in der Entscheidung für einen Suizid: Das Bundesverfassungsgericht hat mit seiner Entscheidung vom 26.02.2020 darauf hingewiesen und damit einen juristischen und gesellschaftlichen Rahmen vorgegeben. Suizid wird so aktuell auf verschiedenen Ebenen unterschiedlich diskutiert. Neue Gesetzesinitiativen wurden im Januar 2022 von Bundestagsabgeordneten vorgestellt. Mit diesem Heft wollen wir einige Themen dieser Diskussion für die „nervenheilkundliche“ Welt darstellen. Dazu gehört das Thema des Zusammenhangs zwischen Corona-Pandemie, Suizidversuchen und Suiziden, das in einem Beitrag von Tobias Teismann und Kollegen dargestellt wird. Weitere klinisch orientierte Beiträge stellen Psychotherapie bei Suizidalität von Tobias Teismann, chronische Suizidalität von Johannes M. Hennings sowie den Einsatz von Ketamin und Esketamin bei Suizidalität von Martin Plöderl und Koautoren dar. Ergänzt wird dies durch eine empirische Studie von Stefanie Geith und Florian Eyer zu Erfahrungen mit der Behandlung von Patienten nach Suizidversuchen auf einer toxikologischen Abteilung. Schließlich wird Psychotherapie akuter Suizidalität dargestellt, ein Thema, das bislang zu wenig Beachtung fand und für das es aber sehr gute Konzepte gibt, die stärker bekannt sein sollten. Die Frage der Prädiktion von Suizidversuchen und die Möglichkeit oder Frage, ob hier künstliche Intelligenz einen Einsatz haben könnten, werden in einem weiteren Beitrag von Tobias Teismann und Kollegen diskutiert: Das ist ein Thema, das insbesondere für Notaufnahmen, Konsilärzte aber auch niedergelassene Kollegen von hoher Bedeutung ist. Im Beitrag der Medizinrechtlerin Tanja Henking et al. wird dann die medizinrechtlich-ethische Seite des Suizides, insbesondere vor dem Hintergrund des Bundesverfassungsgerichtsurteils dargestellt. Das Thema Suizid hat für uns alle, die wir im (weiteren) Bereich von Psychiatrie und Psychotherapie arbeiten, eine grundsätzlich professionelle Seite. Es gibt aber eine zweite Seite, das ist die der persönlichen Erfahrung, der eigenen Werte und Überzeugungen. Wie diese beiden Seiten zusammengehen, kann nicht allgemein beantwortet werden, es ist aber wichtig und bedeutsam ausreichend Informationen zu haben, um sich dieses schwierigen Themas anzunehmen. Wenn wir einen kleinen Beitrag dazu leisten können, dann war für uns dieses Heft erfolgreich. Wir laden Sie nicht nur zum Lesen ein, sondern zum weiter Nachdenken und Diskutieren. Peter Brieger, München, Johannes Hamann, München, und Tobias Teismann, Bochum Publication Date: 04 April 2022 (online) © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 March 2022
- Published by Georg Thieme Verlag KG in Nervenheilkunde
- Vol. 41 (04) , 211
Open AccessSuizid: Wir müssen reden
Suizid ist mehr als ein medizinisches oder psychiatrisches Problem. Das Thema Suizid umfasst medizinische, psychiatrische, psychotherapeutische, psychologische, aber auch philosophische, ethische, juristische, gesellschaftliche und politische Aspekte. Wir erleben hier ein Spannungsfeld: Suizide bringen viel Leid, und es ist eine Aufgabe der Gesellschaft und der Hilfesysteme, Suizide durch Präventionsmaßnahmen zu vermeiden oder durch therapeutische Bemühungen zu verhindern. Suizide widerspiegeln immer wieder ein Verzweifeln am Leben; und wir haben uns zu fragen, welche äußeren Umstände und inneren Zustände für diese Verzweiflung jeweils verantwortlich und wie sie zu verändern sind. Dennoch gibt es auch den Aspekt der persönlichen Freiheit in der Entscheidung für einen Suizid: Das Bundesverfassungsgericht hat mit seiner Entscheidung vom 26.02.2020 darauf hingewiesen und damit einen juristischen und gesellschaftlichen Rahmen vorgegeben. Suizid wird so aktuell auf verschiedenen Ebenen unterschiedlich diskutiert. Neue Gesetzesinitiativen wurden im Januar 2022 von Bundestagsabgeordneten vorgestellt. Mit diesem Heft wollen wir einige Themen dieser Diskussion für die „nervenheilkundliche“ Welt darstellen. Dazu gehört das Thema des Zusammenhangs zwischen Corona-Pandemie, Suizidversuchen und Suiziden, das in einem Beitrag von Tobias Teismann und Kollegen dargestellt wird. Weitere klinisch orientierte Beiträge stellen Psychotherapie bei Suizidalität von Tobias Teismann, chronische Suizidalität von Johannes M. Hennings sowie den Einsatz von Ketamin und Esketamin bei Suizidalität von Martin Plöderl und Koautoren dar. Ergänzt wird dies durch eine empirische Studie von Stefanie Geith und Florian Eyer zu Erfahrungen mit der Behandlung von Patienten nach Suizidversuchen auf einer toxikologischen Abteilung. Schließlich wird Psychotherapie akuter Suizidalität dargestellt, ein Thema, das bislang zu wenig Beachtung fand und für das es aber sehr gute Konzepte gibt, die stärker bekannt sein sollten. Die Frage der Prädiktion von Suizidversuchen und die Möglichkeit oder Frage, ob hier künstliche Intelligenz einen Einsatz haben könnten, werden in einem weiteren Beitrag von Tobias Teismann und Kollegen diskutiert: Das ist ein Thema, das insbesondere für Notaufnahmen, Konsilärzte aber auch niedergelassene Kollegen von hoher Bedeutung ist. Im Beitrag der Medizinrechtlerin Tanja Henking et al. wird dann die medizinrechtlich-ethische Seite des Suizides, insbesondere vor dem Hintergrund des Bundesverfassungsgerichtsurteils dargestellt. Das Thema Suizid hat für uns alle, die wir im (weiteren) Bereich von Psychiatrie und Psychotherapie arbeiten, eine grundsätzlich professionelle Seite. Es gibt aber eine zweite Seite, das ist die der persönlichen Erfahrung, der eigenen Werte und Überzeugungen. Wie diese beiden Seiten zusammengehen, kann nicht allgemein beantwortet werden, es ist aber wichtig und bedeutsam ausreichend Informationen zu haben, um sich dieses schwierigen Themas anzunehmen. Wenn wir einen kleinen Beitrag dazu leisten können, dann war für uns dieses Heft erfolgreich. Wir laden Sie nicht nur zum Lesen ein, sondern zum weiter Nachdenken und Diskutieren. Peter Brieger, München, Johannes Hamann, München, und Tobias Teismann, Bochum Publication Date: 04 April 2022 (online) © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 13 July 2021
- Published by Wiley in Health Expectations
- Vol. 24 (5) , 1737-1746
Barriers and facilitators of shared decision making in acutely ill inpatients with schizophrenia—Qualitative findings from the intervention group of a randomised‐controlled trial
Background: Shared decision making (SDM) is appreciated as a promising model of communication between clinicians and patients. However, in acute mental health settings, its implementation is still unsatisfactory.Objective: The aim of this study is to examine barriers and facilitators of SDM with acutely ill inpatients with schizophrenia.Design: A qualitative interview study was performed.Setting and Participants: The analysis is based on interviews with participants (patients and staff members) of the intervention group of the randomised‐controlled SDMPLUS trial that demonstrated a significant improvement of SDM measures for patients with schizophrenia on acute psychiatric wards.Main Variables Studied: Interviews addressed treatment decisions made during the current inpatient stay. The interviews were analysed using qualitative content analysis.Results: A total of 40 interviews were analysed and 131 treatment decisions were identified. According to the interviewees, SDM had taken place in 29% of the decisions, whereas 59% of the decisions were made without SDM. In 16%, a clear judgement could not be made. Barriers and facilitators of SDM were categorised into patient factors, clinician factors, setting factors and others. Clinicians mostly reported patient factors (e.g., symptoms) as barriers towards SDM, which were not mirrored on the patients' side. Facilitators included patient as well as clinician behaviour during consultations.Conclusion: Even in the context of a successful SDM intervention, the implementation of SDM for patients in the very acute stages of schizophrenia is often not possible. However, strong facilitators for SDM have also been identified, which should be used for further implementation of SDM.Patient or Public Contribution: During the development of the study protocol, meetings with user representatives were held.
- 13 July 2021
- Published by Wiley in Health Expectations
- Vol. 24 (5) , 1737-1746
Open AccessBarriers and facilitators of shared decision making in acutely ill inpatients with schizophrenia—Qualitative findings from the intervention group of a randomised‐controlled trial
Background: Shared decision making (SDM) is appreciated as a promising model of communication between clinicians and patients. However, in acute mental health settings, its implementation is still unsatisfactory.Objective: The aim of this study is to examine barriers and facilitators of SDM with acutely ill inpatients with schizophrenia.Design: A qualitative interview study was performed.Setting and Participants: The analysis is based on interviews with participants (patients and staff members) of the intervention group of the randomised‐controlled SDMPLUS trial that demonstrated a significant improvement of SDM measures for patients with schizophrenia on acute psychiatric wards.Main Variables Studied: Interviews addressed treatment decisions made during the current inpatient stay. The interviews were analysed using qualitative content analysis.Results: A total of 40 interviews were analysed and 131 treatment decisions were identified. According to the interviewees, SDM had taken place in 29% of the decisions, whereas 59% of the decisions were made without SDM. In 16%, a clear judgement could not be made. Barriers and facilitators of SDM were categorised into patient factors, clinician factors, setting factors and others. Clinicians mostly reported patient factors (e.g., symptoms) as barriers towards SDM, which were not mirrored on the patients' side. Facilitators included patient as well as clinician behaviour during consultations.Conclusion: Even in the context of a successful SDM intervention, the implementation of SDM for patients in the very acute stages of schizophrenia is often not possible. However, strong facilitators for SDM have also been identified, which should be used for further implementation of SDM.Patient or Public Contribution: During the development of the study protocol, meetings with user representatives were held.
- 1 May 2021
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 137, 173-177
Differences between suicide note leavers and other suicides: A German psychological autopsy study
- 1 May 2021
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 137, 173-177
Differences between suicide note leavers and other suicides: A German psychological autopsy study
- Open Access
- 15 January 2021
- Published by Wiley in Health Expectations
- Vol. 24 (2) , 507-515
‘Triadic’ shared decision making in mental health: Experiences and expectations of service users, caregivers and clinicians in Germany
Background: Shared decision making (SDM) in mental health may contribute to greater patient satisfaction and is sometimes associated with better health outcomes. Here, SDM should not only involve service users and clinicians but also involve the service users' caregivers.Aim: This study aimed to achieve better insight into the current SDM patterns of triads of service users, caregivers and clinicians in inpatient mental health care and the three parties' expectations towards the prospects of triadic SDM.Design: The current research uses data from a representative cross‐sectional study on caregivers in psychiatric inpatient treatment. We analysed data on n = 94 triads of service users, their caregivers and their clinicians.Results: All three parties acknowledge caregivers to be of great support to monitor the progress with mental disease. The caregiver's role during consultations is most often described as being an expert, receiving or providing information and supporting service users. However, caregivers at times try to seek support for themselves during caregiver‐clinician interaction, or their behaviour was described as unhelpful. The potential prospects of caregiver involvement are clearly acknowledged despite the low implementation of caregiver involvement in this sample (only in one‐third of the cases).Conclusion: Triadic SDM rarely takes place in routine inpatient care. First, there should be a focus on interventions aiming at inviting caregivers to consultations. Only in the second step should a better conceptualisation of triadic SDM be undertaken.Public Contribution: Early results were discussed with a local peer support group for caregivers of individuals living with mental illness.
- 15 January 2021
- Published by Wiley in Health Expectations
- Vol. 24 (2) , 507-515
Open Access‘Triadic’ shared decision making in mental health: Experiences and expectations of service users, caregivers and clinicians in Germany
Background: Shared decision making (SDM) in mental health may contribute to greater patient satisfaction and is sometimes associated with better health outcomes. Here, SDM should not only involve service users and clinicians but also involve the service users' caregivers.Aim: This study aimed to achieve better insight into the current SDM patterns of triads of service users, caregivers and clinicians in inpatient mental health care and the three parties' expectations towards the prospects of triadic SDM.Design: The current research uses data from a representative cross‐sectional study on caregivers in psychiatric inpatient treatment. We analysed data on n = 94 triads of service users, their caregivers and their clinicians.Results: All three parties acknowledge caregivers to be of great support to monitor the progress with mental disease. The caregiver's role during consultations is most often described as being an expert, receiving or providing information and supporting service users. However, caregivers at times try to seek support for themselves during caregiver‐clinician interaction, or their behaviour was described as unhelpful. The potential prospects of caregiver involvement are clearly acknowledged despite the low implementation of caregiver involvement in this sample (only in one‐third of the cases).Conclusion: Triadic SDM rarely takes place in routine inpatient care. First, there should be a focus on interventions aiming at inviting caregivers to consultations. Only in the second step should a better conceptualisation of triadic SDM be undertaken.Public Contribution: Early results were discussed with a local peer support group for caregivers of individuals living with mental illness.
- Open Access
- 28 September 2020
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 63 (1) , 1-25
Shared decision making, aggression, and coercion in inpatients with schizophrenia
Background: The present study aimed at answering three research questions: (a) Does shared decision making (SDM) yield similar effects for patients with involuntary admission or incidents of aggression compared to patients with voluntary admission or without incidents of aggression? (b) Does SDM reduce the number of patients with incidents of aggression and the use of coercive measures? (c) Does the use of coercion have a negative impact on patients’ perceived involvement in decision making?Methods: We used data from the cluster-randomized SDM-PLUS trial in which patients with schizophrenia or schizoaffective disorder in 12 acute psychiatric wards of 4 German psychiatric hospitals either received an SDM-intervention or treatment as usual. In addition, data on aggression and coercive measures were retrospectively obtained from patients’ records.Results: The analysis includedn = 305 inpatients. Patient aggression as well as coercive measures mostly took place in the first days of the inpatient stay and were seldom during the study phase of the SDM-PLUS trial.Patients who had been admitted involuntarily or showed incidents of aggression profited similarly from the intervention with regard to perceived involvement, adherence, and treatment satisfaction compared to patients admitted voluntarily or without incidents of aggression. The intervention showed no effect on patient aggression and coercive measures. Having previously experienced coercive measures did not predict patients’ rating of perceived involvement.Conclusion: Further research should focus on SDM-interventions taking place in the very first days of inpatients treatment and potential beneficial long effects of participatory approaches that may not be measurable during the current inpatient stay.
- 28 September 2020
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 63 (1) , 1-25
Open AccessShared decision making, aggression, and coercion in inpatients with schizophrenia
Background: The present study aimed at answering three research questions: (a) Does shared decision making (SDM) yield similar effects for patients with involuntary admission or incidents of aggression compared to patients with voluntary admission or without incidents of aggression? (b) Does SDM reduce the number of patients with incidents of aggression and the use of coercive measures? (c) Does the use of coercion have a negative impact on patients’ perceived involvement in decision making?Methods: We used data from the cluster-randomized SDM-PLUS trial in which patients with schizophrenia or schizoaffective disorder in 12 acute psychiatric wards of 4 German psychiatric hospitals either received an SDM-intervention or treatment as usual. In addition, data on aggression and coercive measures were retrospectively obtained from patients’ records.Results: The analysis includedn = 305 inpatients. Patient aggression as well as coercive measures mostly took place in the first days of the inpatient stay and were seldom during the study phase of the SDM-PLUS trial.Patients who had been admitted involuntarily or showed incidents of aggression profited similarly from the intervention with regard to perceived involvement, adherence, and treatment satisfaction compared to patients admitted voluntarily or without incidents of aggression. The intervention showed no effect on patient aggression and coercive measures. Having previously experienced coercive measures did not predict patients’ rating of perceived involvement.Conclusion: Further research should focus on SDM-interventions taking place in the very first days of inpatients treatment and potential beneficial long effects of participatory approaches that may not be measurable during the current inpatient stay.